Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon) that suppresses appetite, improves insulin sensitivity, and promotes overall weight loss averaging 24.2% over 48 weeks in clinical trials
Unlike other generic supplements, PeptideComfort is specifically designed to meet the needs of those using GLP-1 and GIP agonist medications like Ozempic, Mounjaro, and Wegovy
Patients often lose a significant percentage of their excess weight after a conversion, with many achieving results that mirror those of a primary bypass procedure
Metabolic health markers: Check blood sugar, blood pressure, and cholesterol every 36 months
It includes examining and planning all the data acquired from the past in advance
Tirzepatide slows gastric motility significantly